zb716
Showing 1 - 1 of 1
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer Trial in Korea, Republic of, United States (ZB716,
Recruiting
- Estrogen Receptor-Positive
- +3 more
- ZB716
- Palbociclib
-
Seattle, Washington
- +7 more
Mar 20, 2022